retatrutide weight loss phase 2 trial results Results: 24% in 48 Weeks Retatrutide Weight Loss Results:Trial Data

[DOI] [PMC free article] [PubMed] [Google Scholar] 55.Mostafa NM, Nader AM, Noertersheuser P, Okun M, Awni WM

Beinaglutide is another short-acting recombinant human GLP-1RA that closely resembles human GLP-1(6-37), approved in China for the indications of type 2 diabetes mellitus and weight loss

Hobart notes that many people report improvements in depressive symptoms following weight loss itself, even without the use of GLP-1 medications

They simply reveal structural changes that were already occurring beneath the surface

Solution: Always warm medication to room temperature before injection

Novo Nordisk explicitly cited the widespread availability of compounded GLP-1s as a factor dampening sales growth in early 2025